Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.141.1.396PMID 10614662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The future of antihormone therapy: innovations based on an established principle

  2005cited by this paper
• Activation of mitogen-activated protein kinase associated with prostate cancer progression.

  1999cited by this paper
• Use of aromatase inhibitors in breast carcinoma.

  1999cited by this paper
• In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

  1998cited by this paper
• Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells.

  1998cited by this paper
• Role of Estrogen and Estrogen-Related Growth Factor in the Mechanism of Hormone Dependency of Endometrial Carcinoma Cells

  1998cited by this paper
• In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.

  1998cited by this paper
• Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.

  1998cited by this paper
• Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells.

  1997cited by this paper
• Effects of 17 beta-estradiol and progesterone on mitogen-activated protein kinase expression and activity in rat uterine smooth muscle.

  1996cited by this paper
• Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

  1996cited by this paper
• Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

  1996cited by this paper
• Responses to Pure Antiestrogens (ICI 164384, ICI182780) in Estrogen‐Sensitive and‐Resistant Experimental and Clinical Breast Cancer a

  1995cited by this paper
• Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.

  1995cited by this paper
• HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

  1995cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• Alterations in Transforming Growth Factor-α and -β Production and Cell Responsiveness during the Progression of MCF-7 Human Breast Cancer Cells to Estrogen-Autonomous Growth

  1994cited by this paper
• A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.

  1994cited by this paper
• Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.

  1994cited by this paper
• Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.

  1994cited by this paper
• Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

  1993cited by this paper
• Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

  1993cited by this paper
• Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

  1992cited by this paper
• Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.

  1991cited by this paper
• Endocrine treatment of breast cancer in women.

  1990influential reference
• Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.

  1990cited by this paper
• Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.

  1990cited by this paper
• Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

  1989cited by this paper
• The control of hormone-dependent breast cancer growth--are we talking about estrogen alone?

  1988cited by this paper
• Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.

  1988cited by this paper
• Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.

  1987cited by this paper
• Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture.

  1987cited by this paper
• Ablative procedures in patients with metastatic breast carcinoma

  1984cited by this paper
• Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma.

  1982cited by this paper
• Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

  1981cited by this paper
• Species distribution of testosterone-binding globulin.

  1973cited by this paper
• Practical Nonparametric Statistics

  1972cited by this paper

• Functional interactions between anteroventral periventricular kisspeptin neurons and gonadotropin-releasing hormone neurons in female mice

  2026cites this paper
• Autophagy signaling mediated by non-coding RNAs: Impact on breast cancer progression and treatment.

  2025cites this paper
• Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers

  2022cites this paper
• Estrogen receptor signaling in the immune system.

  2022cites this paper
• Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer

  2022cites this paper
• Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen

  2021cites this paper
• Neuroendocrine Basis for Disrupted Ovarian Cyclicity in Female Mice During Chronic Undernutrition.

  2021cites this paper
• Reciprocal Changes in Voltage-Gated Potassium and Subthreshold Inward Currents Help Maintain Firing Dynamics of AVPV Kisspeptin Neurons during the Estrous Cycle

  2021cites this paper
• Reciprocal Changes in Voltage-Gated Potassium and Subthreshold Inward Currents Help Maintain Firing Dynamics of AVPV Kisspeptin Neurons during the Estrous Cycle

  2021cites this paper
• A CRH receptor type 1 agonist increases GABA transmission to GnRH neurons in a circulating-estradiol-dependent manner.

  2020cites this paper
• Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells

  2020cites this paper
• Estradiol Enables Chronic Corticosterone to Inhibit Pulsatile Luteinizing Hormone Secretion and Suppress Kiss1 Neuronal Activation in Female Mice

  2019cites this paper
• Hormesis in Health and Chronic Diseases.

  2019cites this paper
• Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer

  2019cites this paper
• Edinburgh Research Explorer Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 random

  2018cites this paper
• Breast cancer metastatic dormancy and emergence, a role for adjuvant statin therapy

  2018cites this paper
• Glutamatergic Transmission to Hypothalamic Kisspeptin Neurons Is Differentially Regulated by Estradiol through Estrogen Receptor α in Adult Female Mice

  2018cites this paper
• Changes in GABAergic Transmission to and Intrinsic Excitability of Gonadotropin-Releasing Hormone (GnRH) Neurons during the Estrous Cycle in Mice

  2018cites this paper
• Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications

  2018cites this paper
• Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

  2018cites this paper
• Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma

  2018cites this paper
• Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells

  2017cites this paper
• Preclinical breast effects of a tissue selective estrogen complex (TSEC) including conjugated estrogen with bazedoxifene.

  2017cites this paper
• Estradiol suppresses phosphorylation of ERα serine 167 through upregulation of PP2A in breast cancer cells.

  2017cites this paper
• GnRH Neuron Activity and Pituitary Response in Estradiol-Induced vs Proestrous Luteinizing Hormone Surges in Female Mice

  2017cites this paper
• Exposure to Acute Psychosocial Stress Disrupts the Luteinizing Hormone Surge Independent of Estrous Cycle Alterations in Female Mice

  2017cites this paper
• Schizandra chinensis exhibits phytoestrogenic effects by regulating the activation of estrogen receptor-α and -β

  2017cites this paper
• Aus der Klinik für Allgemein-, Viszeral- und Gefäßchirurgie der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor in pancreatic ductal adenocarcinoma

  2017cites this paper
• Excitability and Burst Generation of AVPV Kisspeptin Neurons Are Regulated by the Estrous Cycle Via Multiple Conductances Modulated by Estradiol Action123

  2016cites this paper
• Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells.

  2016cites this paper
• Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

  2016cites this paper
• HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells

  2016cites this paper
• Syddansk Universitet HIF 2 contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells

  2016cites this paper
• A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.

  2015cites this paper
• Synthesis of 4,4′‐Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)‐like Activity

  2015cites this paper
• Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways.

  2015cites this paper
• Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

  2015cites this paper
• Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model.

  2015cites this paper
• Östrogenrezeptoren und ihre Bedeutung für die Prognose und Therapie des Lungenkarzinoms – neue Erkenntnisse zu einem bisher unterschätzten Mechanismus

  2015cites this paper
• Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy

  2014influential citation
• Kinome wide functional screen identifies role of Polo-like kinase 1 (PLK1) in hormone-independent, ER-positive breast cancer

  2014cites this paper
• Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.

  2014cites this paper
• Small Molecule Therapeutics Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer

  2014cites this paper
• Hypersensitivity and growth adaptation of oestrogen-deprived MCF-7 human breast cancer cells.

  2014cites this paper
• Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer

  2014cites this paper
• Ameliorative effects of Schizandra chinensis on osteoporosis via activation of estrogen receptor (ER)-α/-β.

  2014cites this paper
• Tracking progesterone receptor-mediated actions in breast cancer.

  2014cites this paper
• Combined cancer therapy: strategies to overcome acquired aromatase inhibitor resistance.

  2014cites this paper
• Effect of estradiol supplementation on blood estradiol and metabolite levels, and hepatic protein expression, in growing, mature, and senescent beef cattle

  2013cites this paper
• Edinburgh Research Explorer Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 random

  2013cites this paper
• Treatment algorithms for hormone receptor-positive advanced breast cancer: going forward in endocrine therapy—overcoming resistance and introducing new agents.

  2013cites this paper
• Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story.

  2013cites this paper
• Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis

  2013cites this paper
• Effects of menopausal hormonal therapy on occult breast tumors.

  2013cites this paper
• The estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?

  2013cites this paper
• Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.

  2013cites this paper
• New Approaches for Hormone-Receptor Positive Metastatic Breast Cancer

  2013cites this paper
• Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.

  2012influential citation
• Estrogen receptor beta in cancer: an attractive target for therapy.

  2012cites this paper
• Expression des Östrogenrezeptors beta beim humanen duktalen Pankreasadenokarzinom und Inhibition der Tumorprogression durch Einsatz des selektiven Östrogenrezeptormodulators Raloxifen

  2012cites this paper
• Molecular mechanisms of oestrogen action on growth of human breast cancer cells in culture

  2012cites this paper
• ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

  2012cites this paper
• Crosstalk with insulin and dependence on PI3K/Akt/mTOR rather than MAPK pathways in upregulation of basal growth following long-term oestrogen deprivation in three human breast cancer cell lines

  2011cites this paper
• Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood.

  2011cites this paper
• Enhanced sensitivity to rapamycin following long-term oestrogen deprivation in MCF-7, T-47-D and ZR-75-1 human breast cancer cells.

  2011cites this paper
• Inhibitory Effects of High Concentrations of Estrogen, Progesterone and Tamoxifen on Proliferation of HeLa in Culture

  2011cites this paper
• Letrozole withdrawal response in locally advanced breast cancer.

  2011cites this paper
• Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance

  2010cites this paper
• Interaction between Cellular Estradiol Response and Receptor Tyrosine Kinase Signaling: Implications for Breast Cancer Therapy

  2010cites this paper
• A hypersensitive estrogen receptor α mutation that alters dynamic protein interactions

  2010cites this paper
• Understanding resistance to endocrine agents: molecular mechanisms and potential for intervention.

  2010cites this paper
• Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

  2010cites this paper
• Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms

  2010cites this paper
• Estrogen Receptor/MAPK Crosstalk as a Mechanism of Radiation Resistance of Breast Cancer

  2010cites this paper
• Overcoming endocrine resistance in breast cancer.

  2010cites this paper
• Aromatase inhibitors: prediction of response and nature of resistance

  2010cites this paper
• Hormone resistance.

  2009cites this paper
• Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.

  2009cites this paper
• Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.

  2009cites this paper
• Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen.

  2009cites this paper
• Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells.

  2009cites this paper
• Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.

  2009cites this paper
• History of aromatase: saga of an important biological mediator and therapeutic target.

  2009cites this paper
• Estradiol-Induced Regression in T47D:A18/PKCα Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix

  2009cites this paper
• Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

  2009cites this paper
• Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues

  2008cites this paper
• Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions

  2008cites this paper
• Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer

  2008cites this paper
• ERBB 2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS 6 KA 2

  2008influential citation
• Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions.

  2008cites this paper
• ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.

  2008cites this paper
• MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.

  2008cites this paper
• Genomics of Signaling Crosstalk of Estrogen Receptor α in Breast Cancer Cells

  2008cites this paper
• Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.

  2008cites this paper
• Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.

  2007cites this paper
• Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients

  2007cites this paper
• Estrogen receptors: how do they signal and what are their targets.

  2007cites this paper
• Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.

  2007cites this paper
• Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

  2007cites this paper
• Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients.

  2007cites this paper